Despite the promising advances in novel cancer therapy such as immune checkpoint
inhibitors (ICIs), limitations including therapeutic resistance and toxicity remain. In recent …

Infection is the second leading cause of death in patients with cancer. Loss of efficacy in
antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing …

Настоящий глобальный доклад о прогрессе в сфере водоснабжения, санитарии,
гигиены, обращения с отходами и санитарной обработки помещений (ВСГ) в …

As COVID-19 rages on, the pandemic of antimicrobial resistance (AMR) continues in the
shadows. The toll taken by AMR on patients and their families is largely invisible but is …

Introduction Rising rates of antimicrobial resistance (AMR) globally continue to pose agrave
threat to human health. Low-and middle-income countries (LMICs) are disproportionately …

BACKGROUND Antimicrobial resistance (AMR) is increasing, driven by widespread
antibiotic use. The wide availability of effective antibiotics is under threat, jeopardizing …

Bacterial infections are a major threat to human health, exacerbated by increasing antibiotic
resistance. These infections can result in tremendous morbidity and mortality, emphasizing …

Background Accurate estimates of the burden of antimicrobial resistance (AMR) are needed
to establish the magnitude of this global threat in terms of both health and cost, and to …

Инфекционные заболевания во всем мире входят в десятку самых распространенных
причин смертности и являются ведущим фактором, обусловливающим годы жизни …

Evidence is growing that the gut microbiota modulates the host response to
chemotherapeutic drugs, with three main clinical outcomes: facilitation of drug efficacy; …